Search
All
LiMM Therapeutics was created to lead development of a new class of therapeutic agents - neuronal reprogrammers of innate lymphocytes. The company is based on pioneering...
Endocontrol was founded in 2006 and designs, manufactures and markets robotic assisted solutions for mini-invasive and laparoscopic surgery. The company offers a motorized...
Domain Therapeutics announces today that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. Since...
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...
Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome. Decision further solidifies Vedanta’s leading IP...
TransferGo hits landmark milestone following successful Series B funding round and an additional $3.4 million investment from Seventure Partners
This funding will enable the company to deploy internationally its latest machine learning technologies for laboratories and biomedical research.
ANI provides an objective, noninvasive, and continuous way to automatically monitor the pain level of patients. The Root platform, with its open architecture and built-in...
New collaboration to evaluate the potential of bacterial antigens that mimic tumor antigens and neoantigens ("onco-mimics") to drive immune responses.
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
